Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06887829 · ClinicalTrials.gov registry record · NA

Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial

A NA study of Osteoarthritis, Knee, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT06887829: Recruiting NA study of Osteoarthritis, Knee, sponsored by Mayo Clinic.

NCT06887829 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 128 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06887829, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to investigate whether low-dose radiotherapy is an effective treatment to reduce the pain of knee osteoarthritis. A secondary aim is to determine whether patients experience any more measurable side effects than those receiving sham treatments.

Primary Outcome

Change in the Intermittent and Constant Osteoarthritis Pain (ICOAP) outcome scale weekly for six months after intervention analyzed as area under the curve of patients with Kellgren-Lawrence grade 2-3 knee OA.

Conditions Studied

Interventions

  • RADIATION Low dose radiotherapy
  • OTHER Sham comparator

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2025-06-04
Est. Completion 2026-06-29
Phase NA
Mayo Clinic

2,844 total trials

What NCT06887829 shows while recruiting

NCT06887829 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Low dose radiotherapy is the first listed.

NCT06887829 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06887829 about?

NCT06887829 is a clinical study titled "Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial". The primary aim of this study is to investigate whether low-dose radiotherapy is an effective treatment to reduce the pain of knee osteoarthritis. A secondary aim is to determine whether patients experience any more measurable side effects than those receiving sham treatments.

What is the current status of trial NCT06887829?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-06-04. Estimated completion is 2026-06-29.

What conditions does trial NCT06887829 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT06887829?

The interventions under investigation include: Low dose radiotherapy (RADIATION), Sham comparator (OTHER).

Who is sponsoring clinical trial NCT06887829?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06887829 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06887829's enrollment target sits among peer trials

128 54th of 112 higher than 59 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06887829, the US trial registry maintained by the National Library of Medicine. NCT06887829 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.